http://medicineworld.org/news/pancreasnews.html MedicineWorld.Org brings daily pancreatic cancer news from various sources to keep you updated on the latest events in the world on this topic. Medicineworld heart watch news service is the most comprehensive heart watch news service on the internet. We keep an archive of previous few days of news on this site. Please go down through the list to find the older news items. Mon, 02 Nov 2009 14:52:56 GMT en-us http://medicineworld.org/images/pancreas.jpg http://medicineworld.org/news/pancreasnews.html 96 77 http://medicineworld.org/stories/lead/11-2009/pancreatic-cancer-risk.html http://medicineworld.org/stories/lead/11-2009/pancreatic-cancer-risk.html Mon, 02 Nov 2009 14:52:56 GMT A Henry Ford Hospital study observed that hepatitis B does not increase the risk for pancreas cancer and that only age is a contributing factor. The results contradict a prior study in 2008 that suggested a link between pancreas cancer and prior hepatitis B infection. Hepatitis B is an inflammation of the liver caused by a viral infection........ ]]> http://medicineworld.org/stories/lead/9-2009/progress-in-pancreatic-cancer.html http://medicineworld.org/stories/lead/9-2009/progress-in-pancreatic-cancer.html Mon, 02 Nov 2009 14:52:56 GMT For the first time scientists have shown that by inhibiting the action of an enzyme called TAK-1, it is possible to make pancreas cancer cells sensitive to chemotherapy, opening the way for the development of a new drug to treat the disease. Dr Davide Melisi told Europe's largest cancer congress, ECCO 15 ESMO 34 [1], in Berlin today (Thursday 24 September) that resistance to chemotherapy was the greatest challenge to treating pancreas cancer........ ]]> http://medicineworld.org/stories/lead/8-2009/metformin-reduces-risk-of-pancreatic-cancer.html http://medicineworld.org/stories/lead/8-2009/metformin-reduces-risk-of-pancreatic-cancer.html Mon, 02 Nov 2009 14:52:56 GMT Taking the most commonly-prescribed anti-diabetic drug, metformin, reduces an individual's risk of developing pancreas cancer by 62 percent, as per research from The University of Texas M. D. Anderson Cancer Center, reported in the Aug. 1 issue of Gastroenterology "This is the first epidemiological study of metformin in the cancer population, and it offers an exciting direction for future chemoprevention research for a disease greatly in need of both therapy and prevention strategies," said Donghui Li, Ph.D., professor in M. D. Anderson's Department of Gastrointestinal Medical Oncology........ ]]> http://medicineworld.org/stories/lead/7-2009/metastatic-pancreatic-cancer.html http://medicineworld.org/stories/lead/7-2009/metastatic-pancreatic-cancer.html Mon, 02 Nov 2009 14:52:56 GMT Smoking has once again been implicated in the development of advanced cancer. Exposure to nicotine by way of cigarette smoking may increase the likelihood that pancreatic ductal adenocarcinoma will become metastatic, as per scientists from the Kimmel Cancer Center at Jefferson. Their study was reported in the August edition of the journal Surgery....... ]]> http://medicineworld.org/stories/lead/4-2009/herbal-extra-to-against-pancreatic-cancer.html http://medicineworld.org/stories/lead/4-2009/herbal-extra-to-against-pancreatic-cancer.html Mon, 02 Nov 2009 14:52:56 GMT An herb recently found to kill pancreas cancer cells also appears to inhibit development of pancreas cancer as a result of its anti-inflammatory properties, as per scientists from the Kimmel Cancer Center at Jefferson. The data were presented at the AACR 100th Annual Meeting 2009 in Denver. (Abstract #494)........ ]]> http://medicineworld.org/stories/lead/4-2009/finding-pancreatic-cancer-early.html http://medicineworld.org/stories/lead/4-2009/finding-pancreatic-cancer-early.html Mon, 02 Nov 2009 14:52:56 GMT A cancer scientist from Johns Hopkins has convinced an international group of colleagues to delay their race to find new cancer biomarkers and instead begin a 7,000-hour slog through a compendium of 50,000 scientific articles already published to assemble, decode and analyze the molecules that might herald the furtive presence of pancreas cancer........ ]]> http://medicineworld.org/stories/lead/2-2009/determining-risk-for-pancreatic-cancer.html http://medicineworld.org/stories/lead/2-2009/determining-risk-for-pancreatic-cancer.html Mon, 02 Nov 2009 14:52:56 GMT In the latest clinical trial for a technique to detect pancreas cancer, scientists found they could differentiate cells that are malignant from those that are benign, pre-malignant, or even early stage indicators called mucinous cystic lesions. Pancreas cancer is dangerous to screen for, yet deadly if ignored. The pancreas is extremely sensitive--biopsies can lead to potentially fatal complications--but with few symptoms, the cancer is commonly detected too late........ ]]> http://medicineworld.org/stories/lead/1-2009/genes-and-pancreatic-cancer.html http://medicineworld.org/stories/lead/1-2009/genes-and-pancreatic-cancer.html Mon, 02 Nov 2009 14:52:56 GMT Abnormalities in genes that repair mistakes in DNA replication may help identify people who are at high risk of developing pancreas cancer, a research team from The University of Texas M. D. Anderson Cancer Center reports in the Jan. 15 issue of Clinical Cancer Research Defects in these critical DNA repair genes may act alone or in combination with traditional risk factors known to increase an individual's likelihood of being diagnosed with this very aggressive type of cancer........ ]]> http://medicineworld.org/stories/lead/1-2009/new-gene-to-predict-outcome-in-pancreatic-cancer.html http://medicineworld.org/stories/lead/1-2009/new-gene-to-predict-outcome-in-pancreatic-cancer.html Mon, 02 Nov 2009 14:52:56 GMT Variations in mismatch repair genes can help predict therapy response and prognosis in patients with pancreas cancer, as per research from The University of Texas M. D. Anderson Cancer Center presented today in advance of the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium........ ]]> http://medicineworld.org/stories/lead/1-2009/hepatitis-c-may-increase-pancreatic-cancer-risk.html http://medicineworld.org/stories/lead/1-2009/hepatitis-c-may-increase-pancreatic-cancer-risk.html Mon, 02 Nov 2009 14:52:56 GMT A newly released study shows that infection with hepatitis C virus (HCV) increases a person's risk for a highly fatal cancer of the biliary tree, the bile carrying pathway between the liver and pancreas. This finding is in the recent issue of Hepatology, a journal published by John Wiley and Sons on behalf of the American Association for the Study of Liver Diseases (AASLD). The article is also available online at Wiley Interscience (www.interscience.wiley.com)........ ]]> http://medicineworld.org/cancer/lead/11-2008/radiation-before-surgery-improves.html http://medicineworld.org/cancer/lead/11-2008/radiation-before-surgery-improves.html Mon, 02 Nov 2009 14:52:56 GMT Pancreas cancer is one of the deadliest and most difficult to treat cancers. Now, in a major step forward, scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center have shown that administering radiation treatment previous to surgery nearly doubles survival in pancreas cancer patients with operable tumors........ ]]> http://medicineworld.org/cancer/lead/10-2008/new-pancreas-tumor-registry.html http://medicineworld.org/cancer/lead/10-2008/new-pancreas-tumor-registry.html Mon, 02 Nov 2009 14:52:56 GMT Charles J. Yeo, M.D., Samuel D. Gross Professor and Chair, Department of Surgery at Jefferson Medical College of Thomas Jefferson University, announces the establishment of the new Jefferson Pancreas Tumor Registry (JPTR). "The purpose of the registry is to further study whether pancreas cancer occurs more frequently in families with a history of the disease," said Dr. Yeo, who is the principal investigator of JPTR. "It will also be used to determine the environmental and occupational risk factors to which pancreas cancer patients have been exposed."....... ]]> http://medicineworld.org/cancer/lead/9-2008/hepatitis-b-exposure-and-pancreatic-cancer.html http://medicineworld.org/cancer/lead/9-2008/hepatitis-b-exposure-and-pancreatic-cancer.html Mon, 02 Nov 2009 14:52:56 GMT HOUSTON - In a first-of-its-kind finding, scientists at The University of Texas M. D. Anderson Cancer Center have discovered that exposure to the hepatitis B virus (HBV) may increase the risk of pancreas cancer. The study, reported in the Oct. 1 edition of the Journal of Clinical Oncology, also suggests that patients with this lethal form of cancer treated with chemotherapy may face danger of reactivation of their HBV........ ]]> http://medicineworld.org/cancer/lead/9-2008/prevention-and-treatment-of-pancreatic-cancer.html http://medicineworld.org/cancer/lead/9-2008/prevention-and-treatment-of-pancreatic-cancer.html Mon, 02 Nov 2009 14:52:56 GMT A number of gastrointestinal tumors, including pancreas cancer, have been shown to overexpress the EGFR. The overexpression of EGFR correlates with rapidly progressive disease and poor prognosis. Targeting EGFR pathway as a potential therapeutic strategy for pancreas cancer has been developed. Erlotinib is a small molecule tyrosine kinase inhibitor that efficiently blocks EGFR. Preliminary results of phase III trial in pancreas cancer revealed an improvement in survival with the addition of erlotinib. Treatment with anti-EGFR agents is used as a potential therapeutic strategy for pancreas cancer, but the mechanisms are still not precisely understood........ ]]> http://medicineworld.org/cancer/lead/9-2008/new-drug-extends-survival-in-pancreatic-cancer.html http://medicineworld.org/cancer/lead/9-2008/new-drug-extends-survival-in-pancreatic-cancer.html Mon, 02 Nov 2009 14:52:56 GMT A new form of chemotherapy that destroys new blood vessels that grow around tumors has produced excellent results in a phase II trial of patients with inoperable pancreas cancer, scientists report at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm. European researchers led by Prof. Matthias Lhr from the Karolinska Institute reviewed the efficacy and safety of three different doses of cationic lipid complexed paclitaxel (EndoTAG-1) administered twice weekly, in combination with weekly infusions of gemcitabine, in comparison to gemcitabine alone, in 200 patients with pancreatic adenocarcinoma........ ]]>